The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
Drug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 rece...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/full |
id |
doaj-b7791248436c46198c2019d444536370 |
---|---|
record_format |
Article |
spelling |
doaj-b7791248436c46198c2019d4445363702020-11-24T22:44:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-10-01810.3389/fphar.2017.00714305488The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the StriatumAnna M. Klawonn0Anna Nilsson1Carl F. Rådberg2Sarah H. Lindström3Mia Ericson4Björn Granseth5David Engblom6Michael Fritz7Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenAddiction Biology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenDrug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 receptors have been meticulously studied in psychostimulant reinforced Pavlovian learning, while the sigma-2 receptor subtype has remained unexplored. Recent development of selective sigma-2 receptor ligands have now made it possible to investigate if the sigma-2 receptor system is a potential target to treat drug addiction. We examined the effect of the sigma-2 receptor agonist Siramesine (Lu 28-179) on cocaine-associated locomotion, Pavlovian learning, and reward neurocircuitry using electrophysiology recordings and in vivo microdialysis. We found that Siramesine significantly attenuated conditioned place preference acquisition and expression, as well as it completely blocked cocaine-primed reinstatement. Siramesine, in a similar manner as the selective sigma-1 receptor antagonist BD 1063, decreased acute locomotor responses to cocaine. Immunohistochemistry suggests co-expression of progesterone receptor membrane component 1/sigma-2 receptors and vesicular glutamate transporter 1 in presynaptic boutons of the nucleus accumbens (NAc). Whole-cell voltage clamp recordings of neurons in the NAc indicated that Siramesine decreases the presynaptic release probability of glutamate. Further, we demonstrated, via in vivo microdialysis, that Siramesine significantly decreased cocaine-evoked dopamine release in the striatum of freely moving mice. Collectively, these findings demonstrate that sigma-2 receptors regulate neurocircuitry responsible for positive reinforcement and thereby play a role in cocaine-reinforced Pavlovian behaviors.http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/fulladdictioncocaineconditioned place preferencesigma-receptorSiramesineelectrophysiology |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anna M. Klawonn Anna Nilsson Carl F. Rådberg Sarah H. Lindström Mia Ericson Björn Granseth David Engblom Michael Fritz |
spellingShingle |
Anna M. Klawonn Anna Nilsson Carl F. Rådberg Sarah H. Lindström Mia Ericson Björn Granseth David Engblom Michael Fritz The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum Frontiers in Pharmacology addiction cocaine conditioned place preference sigma-receptor Siramesine electrophysiology |
author_facet |
Anna M. Klawonn Anna Nilsson Carl F. Rådberg Sarah H. Lindström Mia Ericson Björn Granseth David Engblom Michael Fritz |
author_sort |
Anna M. Klawonn |
title |
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
title_short |
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
title_full |
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
title_fullStr |
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
title_full_unstemmed |
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum |
title_sort |
sigma-2 receptor selective agonist siramesine (lu 28-179) decreases cocaine-reinforced pavlovian learning and alters glutamatergic and dopaminergic input to the striatum |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2017-10-01 |
description |
Drug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 receptors have been meticulously studied in psychostimulant reinforced Pavlovian learning, while the sigma-2 receptor subtype has remained unexplored. Recent development of selective sigma-2 receptor ligands have now made it possible to investigate if the sigma-2 receptor system is a potential target to treat drug addiction. We examined the effect of the sigma-2 receptor agonist Siramesine (Lu 28-179) on cocaine-associated locomotion, Pavlovian learning, and reward neurocircuitry using electrophysiology recordings and in vivo microdialysis. We found that Siramesine significantly attenuated conditioned place preference acquisition and expression, as well as it completely blocked cocaine-primed reinstatement. Siramesine, in a similar manner as the selective sigma-1 receptor antagonist BD 1063, decreased acute locomotor responses to cocaine. Immunohistochemistry suggests co-expression of progesterone receptor membrane component 1/sigma-2 receptors and vesicular glutamate transporter 1 in presynaptic boutons of the nucleus accumbens (NAc). Whole-cell voltage clamp recordings of neurons in the NAc indicated that Siramesine decreases the presynaptic release probability of glutamate. Further, we demonstrated, via in vivo microdialysis, that Siramesine significantly decreased cocaine-evoked dopamine release in the striatum of freely moving mice. Collectively, these findings demonstrate that sigma-2 receptors regulate neurocircuitry responsible for positive reinforcement and thereby play a role in cocaine-reinforced Pavlovian behaviors. |
topic |
addiction cocaine conditioned place preference sigma-receptor Siramesine electrophysiology |
url |
http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/full |
work_keys_str_mv |
AT annamklawonn thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT annanilsson thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT carlfradberg thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT sarahhlindstrom thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT miaericson thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT bjorngranseth thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT davidengblom thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT michaelfritz thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT annamklawonn sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT annanilsson sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT carlfradberg sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT sarahhlindstrom sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT miaericson sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT bjorngranseth sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT davidengblom sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum AT michaelfritz sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum |
_version_ |
1725691784905883648 |